Media-OutReach Newswire Humansa's Signature Future Health Program Integrated into AIA's New Optima CEO Medical Plan
Media-OutReach Newswire Daiken Biomedical’s Q10-Natto Plus Red Yeast Rice Complex Receive 2023 Japanese Patent for Formulation
Media-OutReach Newswire The United Laboratories International Holdings Limited Applies for the Clinical Trial of its Class 1 Innovative New Drug UBT251 Injection
Media-OutReach Newswire Boan Biotech Announces 2022 Financial Results, Showing Accelerated Innovation and Strong 225% Revenue Growth
Media-OutReach Newswire Hong Kong Baptist University develops new aptamer drug for bone anabolic therapies
Media-OutReach Newswire Alphacelle Introduces Integrated Stem Cell Solutions Amidst Rising Degenerative Diseases Amongst Malaysians